Behind each adaptation of the living is hiding a refined strategy, refined by millions of years of evolution. Some snakes have made it a formidable weapon, both subtle and brutal. This is the case of Mamba's venom, whose complexity is today shaking up certainties of biologists as doctors.
This double action is based on distinct targets from the nervous system. Flash toxins act on postsynaptic receptors and block communication between nerves and muscles. On the other hand, spasmodic toxins cause excessive release of acetylcholine upstream, at the presynaptic level, which leads to muscle hyperstimulation. The victims then move from a lethargy to a painful tension which can lead to death if it is not controlled quickly.
Why Mamba's venom defies existing antivenins
Until recently, the available antivenines mainly targeted toxins responsible for flaccid paralysis. This approach seemed sufficient to treat the symptoms observed in the clinic. However, the Australian study published in the journal Toxins has shown that these treatments, by neutralizing the first toxins, actually release the effects of secondary toxins hitherto masked. It is the equivalent of extinguishing a fire to reveal another, deeper.
The researchers tested the venom of four species of Mambas on nerve preparations of chicks. They observed that antivenines effectively neutralized postsynaptic effects but left the presynaptic action intact. Experience has also highlighted important variations according to the geographic origin of snakes. The venom of the Kenya Black Mambas does not react in the same way as that of their South African counterparts. The same antivenin formulation can therefore be effective in one region and ineffective in another, which seriously complicates the care protocols.
By relying on this data, Professor Bryan Fry, specialist in animal toxins, stresses that these results could explain why some patients were initially stabilized before brutally relapse. This discovery therefore highlights a critical flaw in current treatments.
Towards a new generation of antivenines to save lives
The extent of the phenomenon exceeds simple scientific curiosity. Each year, Mambas bites lead to approximately 30,000 deaths in sub -Saharan Africa, according to estimates relayed by Eurekalert. An inadequate management, even rapid, can thus have fatal consequences. The need for a new generation of antivenines is becoming urgent. Current formulations must be redesigned to neutralize both postsynaptic and presynaptic effects.
The work carried out jointly by the University of Queensland and the Monash Venom Group open a way to more specific antivenines, capable of dealing with the toxic diversity of the different species of Mamba. The researchers have shown that this complexity is not due to the appearance of new types of toxins but to a variation in the expression of toxins already present in the common ancestor of Mambas. This evolutionary subtlety requires designing treatments adapted to this unique synergy, where the effects of toxins are not replaced but follow one another to better trap the organism.
Beyond medical implications, these results recall that nature sometimes evolves in finesse rather than breaking. Mamba's venom embodies this formidable strategy, where the attack does not come at once but in two salvas, like a chemical ambush orchestrated with precision. Under these conditions, improving treatments is not solely of pharmacology but also a fine understanding of evolutionary biology.
With an unwavering passion for local news, Christopher leads our editorial team with integrity and dedication. With over 20 years’ experience, he is the backbone of Wouldsayso, ensuring that we stay true to our mission to inform.
